Market Cap (In CNY)
11.71 Billion
Revenue (In CNY)
2.04 Billion
Net Income (In CNY)
581.19 Million
Avg. Volume
944.94 Thousand
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 16.27-25.26
- PE
- -
- EPS
- -
- Beta Value
- 0.639
- ISIN
- CNE100000FM9
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Kailie Liu
- Employee Count
- -
- Website
- https://www.cheezheng.com.cn
- Ipo Date
- 2009-08-28
- Details
- Tibet Cheezheng Tibetan Medicine Co., Ltd. together with its subsidiaries, engages in the research, development, production, and sale of Tibetan medicine in China. It provides drug products in the areas of cardiovascular, respiratory, digestive, urinary and reproductive system, nervous system, musculoskeletal system, and gynecological disorders. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.
More Stocks
-
8447MS Concept Limited
8447
-
WISA
-
LRLCYL'Oréal S.A.
LRLCY
-
300531Urovo Technology Co., Ltd.
300531
-
000705
-
0519
-
267250HD Hyundai Co., Ltd.
267250
-
002675